An unprecedented volume of funding has flowed around the world in response to Covid-19
The mobilisation of R&D to fight Covid-19 has outstripped the response to any infectious disease outbreak in history. The successful development of effective vaccines has been compared with research triumphs such as the space race and the development of nuclear weapons in the Manhattan Project. But unlike such previous research races, which were proxy battles between individual superpowers, the research response to the coronavirus pandemic has been a global effort.
Nonetheless, tensions between national interests and international collaboration have been at play since the Sars-Cov-2 virus was first identified. Trends in how countries have funded Covid-19 R&D illustrate these and are likely to impact how the world moves from response to recovery.